Friday 6 November 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024.

Revenue: +80.1%
EPS: +80.0%
Free cash flow: +89.7%

Quarter to September 2026, against a year earlier

7.99 0.25 +3.23%

Follow IOVA

Alert me

Market cap: $3.5B
P/E: 0.0×
Fwd P/E: −18.9×
Dividend yield: —
F-score: 4/9
Altman Z: −2.30
Beneish M: −2.46
Dividend safety: n/a

Overview

Iovance Biotherapeutics, Inc. (IOVA) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Iovance Biotherapeutics, Inc. (IOVA) trades at a P/S ratio of 9.3×. Over the past ten years it has ranged from 0.0× (March 2024) to 1,984× (April 2024); the current reading is higher than 90% of that period. That is in line with the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IOVA/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Iovance Biotherapeutics, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IOVA/metrics/ps-ratio">Iovance Biotherapeutics, Inc. (IOVA) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	3.7×	(71.68%)
FY2024	13.1×	—
FY2023	0.0×	—

Period	P/S ratio	Change
Sep 2026	17.6×	205.47%
Jun 2026	5.8×	12.05%
Mar 2026	5.1×	38.92%
Dec 2025	3.7×	17.37%
10 more quarters	Free account

Against its own ten years

Low 0.0× High 1,984×

Ten-year median 0.0×

Current reading's percentile 90

Company	P/S ratio
PBLS Parabilis Medicines, Inc. compare	n/m
EWTX Edgewise Therapeutics, Inc. compare	n/m
IRON Disc Medicine, Inc. compare	n/m
ACAD ACADIA Pharmaceuticals Inc. compare	3.1×
IOVA Iovance Biotherapeutics, Inc.	9.3×
TNGX Tango Therapeutics, Inc. compare	51.0×
ABCL AbCellera Biologics Inc. compare	51.9×
XENE Xenon Pharmaceuticals Inc. compare	223×
RLAY Relay Therapeutics, Inc. compare	313×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Iovance Biotherapeutics, Inc. (IOVA) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IOVA

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on IOVA

Stockrow Weekly